The 90% Effective Dose of Nalbuphine in Mechanical Ventilated Patients in the ICU
Status:
Unknown status
Trial end date:
2019-10-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to determine the effective nalbuphine dose in 90% of intubated
patients in the ICU, including the continuous infusion dose and a bolus dose during moving to
the lateral decubitus position. Pain will assessed using a Behavioural Pain Scale (BPS)
requiring a score of 3-4.